Advertisement

AstraZeneca Says Too Early to Speculate on Vaccine Regulation

Nov.23 -- AstraZeneca Executive Vice President Biopharmaceuticals Business Unit President Ruud Dobber discusses the company’s coronavirus vaccine and questions being raised by analysts about its efficacy. He speaks on "Bloomberg Markets."